These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10669940)

  • 1. Camouflaged blood cells: low-technology bioengineering for transfusion medicine?
    Scott MD; Bradley AJ; Murad KL
    Transfus Med Rev; 2000 Jan; 14(1):53-63. PubMed ID: 10669940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular camouflage: fooling the immune system with polymers.
    Scott MD; Murad KL
    Curr Pharm Des; 1998 Dec; 4(6):423-38. PubMed ID: 10197054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen.
    Tan Y; Qiu Y; Xu H; Ji S; Li S; Gong F; Zhang Y
    Transfusion; 2006 Dec; 46(12):2122-7. PubMed ID: 17176324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the red cell: pegylation of other blood cells and tissues.
    Scott MD; Chen AM
    Transfus Clin Biol; 2004 Feb; 11(1):40-6. PubMed ID: 14980548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors.
    Le Y; Toyofuku WM; Scott MD
    Exp Hematol; 2017 Mar; 47():36-47.e2. PubMed ID: 27864153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential utility of methoxypoly(ethylene glycol)-mediated prevention of rhesus blood group antigen RhD recognition in transfusion medicine.
    Wang D; Toyofuku WM; Scott MD
    Biomaterials; 2012 Apr; 33(10):3002-12. PubMed ID: 22264524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DePEGylation studies: PEG-RBC stability in conditions consistent with massive transfusion.
    Moore MS; Okelberry E; Cordingley K; Drake A; Robinett Z
    Clin Lab Sci; 2011; 24(4):227-32. PubMed ID: 22288221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quest for universal red cell units.
    Mohanty D
    Indian J Med Res; 2007 Sep; 126(3):174-5. PubMed ID: 18037708
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol).
    Murad KL; Mahany KL; Brugnara C; Kuypers FA; Eaton JW; Scott MD
    Blood; 1999 Mar; 93(6):2121-7. PubMed ID: 10068687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rh antigen stability of mPEG modified red blood cells].
    Qiu Y; Zha Y; Tan YX; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1020-3. PubMed ID: 17096911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion.
    Garratty G
    Vox Sang; 2008 Feb; 94(2):87-95. PubMed ID: 18034787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future applications of immunological attenuation via pegylation of cells and tissue.
    Chen AM; Scott MD
    BioDrugs; 2001; 15(12):833-47. PubMed ID: 11784214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells.
    Nacharaju P; Boctor FN; Manjula BN; Acharya SA
    Transfusion; 2005 Mar; 45(3):374-83. PubMed ID: 15752155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of irregular antibodies in the department of transfusion medicine 1984-1988].
    Wittkopf D; Grundmann A; Sibrowski W; von Eisenhart-Rothe V; Kühnl P
    Beitr Infusionsther; 1990; 26():415-9. PubMed ID: 1703889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of transfusable human universal red blood cell with recombinant alpha-galactosidase].
    Gong F; Lü QS; You Y; Gao HW; Bao GQ; Gao X; Li SB; Li LL; Wang YL; Tian SG; Zhang ZX; Zhang P; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):313-6. PubMed ID: 15854299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polymer architecture on antigens camouflage, CD47 protection and complement mediated lysis of surface grafted red blood cells.
    Chapanian R; Constantinescu I; Rossi NA; Medvedev N; Brooks DE; Scott MD; Kizhakkedathu JN
    Biomaterials; 2012 Nov; 33(31):7871-83. PubMed ID: 22840223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiolation mediated pegylation platform to generate functional universal red blood cells.
    Nacharaju P; Manjula BN; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):107-18. PubMed ID: 17364475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter.
    Bradley AJ; Murad KL; Regan KL; Scott MD
    Biochim Biophys Acta; 2002 Apr; 1561(2):147-58. PubMed ID: 11997115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.